Trial Information
Registry for Patients With WT1 Mutation Associated Diseases
Inclusion Criteria:
- Germline mutation in WT1 gene
Exclusion Criteria:
- none
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Principal Investigator
Anja Lehnhardt, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Universitätsklinikum Hamburg-Eppendorf
Authority:
Germany: Ethics Commission
Study ID:
WT1 Registry
NCT ID:
NCT01252901
Start Date:
October 2010
Completion Date:
Related Keywords:
- Denys-Drash Syndrome
- Frasier Syndrome
- Nephrotic Syndrome
- Wilms Tumor
- WT1
- Wilms Tumor
- Denys-Drash Syndrome
- Nephrotic Syndrome
- Proteinuria
- Wilms Tumor
- Nephrotic Syndrome
- Denys-Drash Syndrome
- Frasier Syndrome